Antibiotic Ear Drops May Pose Eardrum Risk

Antibiotic Ear Drops May Pose Eardrum Risk

Antibiotic ear drops commonly prescribed to children after ear tube surgery may increase risk for perforated eardrums.

The antibiotics in question are known as quinolones. Researchers looked at data on more than 100,000 children that had ear tube surgery and found that those treated with quinolone ear drops after the procedure were 60% more likely to experience perforated eardrums compared to those who received neomycin drops, another type of antibiotic.

Also, the risk may be higher if steroids are given in addition to the quinolone drops, the researchers reported in the journal Clinical Infectious Diseases.

This is not the first time quinolones have come under fire. Last year, the FDA warned that fluoroquinolones – which account for most of the quinolones prescribed – should be limited due to a risk of potentially permanent side effects.


Jonathan Block

Jonathan Block

Jonathan Block is MedShadow's content editor. He has previously worked for Psychiatry Advisor, Modern Healthcare, Health Reform Week and The Pink Sheet.


Did you find this article helpful?


Latest News

News Scan: Breast Cancer, THC Overdose, Carpal Tunnel Syndrome, Junk Food

News Scan: Breast Cancer, THC Overdose, Carpal Tunnel Syndrome, Junk Food

Breast cancer tops the list this week with two research studies concluding worse news than expected. For those who continue to claim that no one overdoses on cannabis or THC, see the story below. Never underestimate how much people will underestimate the power of “herbs” to harm. Carpal tunnel brought…

News Scan: Warfarin, A-Fib, Lavender Oil and Dopamine Agonist Medicine

News Scan: Warfarin, A-Fib, Lavender Oil and Dopamine Agonist Medicine

Every so often a lay person like me slaps her forehead and says out loud, “what took so long?” A veggie works better than a medicine, why not use the veggie? Talking to patients in their home leads to better understanding by the patients? Of course. And less intuitive but…